Integration of Genome-Wide Computation DRE Search, AhR ChIP-chip and Gene Expression Analyses of TCDD-Elicited Responses in the Mouse Liver by Dere, Edward et al.
RESEARCH ARTICLE Open Access
Integration of Genome-Wide Computation DRE
Search, AhR ChIP-chip and Gene Expression
Analyses of TCDD-Elicited Responses in the
Mouse Liver
Edward Dere
1, Raymond Lo
2, Trine Celius
2, Jason Matthews
2 and Timothy R Zacharewski
1,3*
Abstract
Background: The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor (TF) that mediates
responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Integration of TCDD-induced genome-wide AhR
enrichment, differential gene expression and computational dioxin response element (DRE) analyses further
elucidate the hepatic AhR regulatory network.
Results: Global ChIP-chip and gene expression analyses were performed on hepatic tissue from immature
ovariectomized mice orally gavaged with 30 μg/kg TCDD. ChIP-chip analysis identified 14,446 and 974 AhR
enriched regions (1% false discovery rate) at 2 and 24 hrs, respectively. Enrichment density was greatest in the
proximal promoter, and more specifically, within ± 1.5 kb of a transcriptional start site (TSS). AhR enrichment also
occurred distal to a TSS (e.g. intergenic DNA and 3’ UTR), extending the potential gene expression regulatory roles
of the AhR. Although TF binding site analyses identified over-represented DRE sequences within enriched regions,
approximately 50% of all AhR enriched regions lacked a DRE core (5’-GCGTG-3’). Microarray analysis identified 1,896
number of TCDD-responsive genes (|fold change| ≥ 1.5, P1(t) > 0.999). Integrating this gene expression data with
our ChIP-chip and DRE analyses only identified 625 differentially expressed genes that involved an AhR interaction
at a DRE. Functional annotation analysis of differentially regulated genes associated with AhR enrichment identified
overrepresented processes related to fatty acid and lipid metabolism and transport, and xenobiotic metabolism,
which are consistent with TCDD-elicited steatosis in the mouse liver.
Conclusions: Details of the AhR regulatory network have been expanded to include AhR-DNA interactions within
intragenic and intergenic genomic regions. Moreover, the AhR can interact with DNA independent of a DRE core
suggesting there are alternative mechanisms of AhR-mediated gene regulation.
Background
The aryl hydrocarbon receptor (AhR) is a ligand activated
transcription factor (TF) belonging to the basic-helix-
loop-helix-PAS (bHLH-PAS) family of proteins that serve
as environmental sensors [1]. 2,3,7,8-Tetrachlorodibenzo-
p-dioxin (TCDD) is the prototypical AhR ligand, a ubi-
quitous environmental contaminant that elicits diverse
species-specific effects, including tumor promotion, tera-
togenesis, hepatotoxicity, modulation of endocrine
systems, immunotoxicity and enzyme induction [2,3].
These effects result from alterations in gene expression
mediated by the AhR [4]. Several studies have demon-
strated the requirement for the AhR in mediating
TCDD-elicited responses. For example, mice carrying
low-affinity AhR alleles are less susceptible to the effects
elicited by TCDD [5]. Additionally, AhR-null mice fail to
induce responses typically observed following treatment
with TCDD and related compounds [6].
TCDD binding to the cytosolic AhR results in a confor-
mational change and translocation to the nucleus. The
activated AhR complex heterodimerizes with the aryl
hydrocarbon nuclear translocator (ARNT), another
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elements (DREs) containing the substitution intolerant
5’-GCGTG-3’ core sequence to regulate changes in gene
expression [4,7]. Computational searches for all DRE
cores in the human, mouse and rat genome identified the
highest density of DREs proximal to a transcriptional
start site (TSS) [8]. However, a significant number
of DRE cores and putative functional DREs have been
identified in distal regions within non-coding intergenic
segments of the genome. It has been proposed that
enrichments for other TFs on outlying regions may be
functionally relevant through tertiary looping of genomic
DNA and/or via protein tethering mechanisms [9].
The role of specific transcriptional regulators has been
studied on a gene-by-gene basis, primarily focusing on
regions proximal to the TSS. However, the coupling of
chromatin immunoprecipitation with either genomic tiling
microarrays (ChIP-chip) or next-generation sequencing
(ChIP-seq) has facilitated genome-wide analysis of pro-
tein-DNA interactions for a variety of receptors [10-16],
TFs [17-20] and components of the basal transcriptional
machinery [10,21,22]. Genome-wide location analyses
further suggest that TF binding at cis-regulatory enhancers
in intergenic DNA regions of the genome may also have
functional significance [10,17,23,24].
Several studies have investigated AhR-mediated gene
expression responses using various technologies [25-30].
Although AhR-DNA interactions have primarily focused
on the regulation of CYP1A1 [4,31], recent global ChIP
studies have extended our knowledge of AhR-DNA inter-
actions by examining promoter region binding profiles
using in vitro and in vivo models [32-35] (Lo et al., in sub-
mission). Our study provides a comprehensive analysis by
examining TCDD-induced AhR binding across the entire
mouse genome. In addition, we examined AhR binding
within chromosomes, intragenic and intergenic DNA
regions, and in specific genic regions (i.e., 10 kb upstream
of a TSS, 5’ and 3’ untranslated regions [UTRs], coding
sequence [CDS]). Global AhR enrichment data are also
integrated with computational DRE core analysis [8], and
complementary whole-genome gene expression profiling
to provide a more comprehensive evaluation of the hepatic
AhR regulatory network elicited by TCDD.
Results
Identification and Characterization of TCDD-Elicited AhR
Enrichment
In order to identify regions of AhR enrichment induced by
TCDD across the genome, ChIP-chip assays were per-
formed using hepatic tissue from immature ovariecto-
mized mice orally gavaged with 30 μg/kg TCDD for 2 and
24 hrs. CisGenome [36] analysis identified 22,502 and
12,677 enriched regions at 2 and 24 hrs, respectively.
Applying a conservative FDR of 0.01 resulted in 14,446
and 974 significant AhR enriched regions at 2 and 24 hrs,
respectively (Additional Files 1 and 2 provides a complete
list of enriched regions). Ligand activation of the AhR
in vivo triggers its own rapid degradation and causing a
significant reduction of AhR levels [37,38]. This is
reflected in the significantly lower number of TCDD-
induced AhR enriched regions at 24 hrs as compared to 2
hrs. The distribution, location and enrichment values for
each tiled probes across the Cyp1a1 gene (represented by
RefSeq sequences NM_009992 and NM_001136059) are
summarized in Figure 1. MA value plots visualize the pro-
file of the enriched region and log2 fold-enrichment values
for each probe are also illustrated (Figure 1). Note that the
probes are unevenly tiled throughout the genome, result-
ing in gaps in genome coverage that may coincide with
DRE core locations that may affect AhR enriched region
identification. For example, two enriched regions were
associated with Cyp1a1 (Figure 1, red bars). However, the
MA plots for 2 and 24 hrs suggest that there is only one
large region of enrichment divided into two as a result of
the uneven tiling. Consequently, uneven tiling and the lack
of tiling in regions that contain DREs may affect the esti-
mated number of AhR enriched regions.
Genomic regions with significant AhR enrichment were
mapped to intragenic (10 kb upstream of a TSS plus the
transcribed gene of mature RefSeq sequences) and non-
coding intergenic regions (Table 1; Additional File 3).
Most regions were enriched 5.7-fold with values ranging
from 1.7- to 111.4-fold (Figures 2A-B). Enriched regions
varied in width from 108 to 6,990 bp (Figure 2C) with
90.5% spanning ≤ 1,500 bp. There was no correlation
between fold enrichment and region width (data not
shown). Of the 974 significantly enriched regions at
24 h 899 of them overlapped with a 2 hr enriched
region (Figure 2D), consistent with reports of constant
shuttling of the AhR between the nucleus and cytoplasm
[39], and AhR promoter occupancy of targeted genes in
untreated cells [34]. Relaxing the FDR to 0.05 increased
the overlap to 906, while reducing the number of 24 hr
specific enriched regions to 68. Comparable overlaps
were identified in promoter-specific ChIP-chip studies
of TCDD-induced AhR enrichment at 2 and 24 hrs in
the livers of intact C57BL/6 mice, which identified 1,397
number of genes with 403 overlap (Lo et al., in submis-
sion). Further analysis of the 899 enriched regions found
that the fold enrichment values from both time points
were positively correlated (Pearson correlation coeffi-
cient = 0.4853, two-tailed p-value < 0.0001; Figure 2E).
Although only 40% of the mouse genome consists of
intragenic DNA, 71.8% and 64.7% of all sites with signif-
icant AhR enrichment at 2 hrs and 24 hrs, respectively,
were within this region. The density of AhR enrichment
(per million base pairs [Mbp]) was calculated across the
entire genome in order to consider the cumulative
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Genome and chromosomal analyses (Additional Files 4
and 5) revealed increased enrichment within intragenic
regions compared to non-coding intergenic regions
further illustrating a bias for gene encoding regions.
However, these values may be inflated due to incom-
plete probe coverage in the intergenic regions and
sequence gaps in the genome. Specific analysis of the 10
kb upstream, 5’ and 3’ UTRs and CDS regions revealed
the highest density of AhR enrichment was proximal to
the TSS (Table 1 and Additional Files 4 and 5). AhR
enrichment density was greatest within ± 1.5 kb at 2
and 24 hrs (Figures 3A-B), coinciding with proximal
promoter DRE core densities [8] and RNA polymerase
II binding at the TSSs [10]. Interestingly, there is a nota-
ble cleft in AhR enrichment 200 bp directly upstream
and downstream of the TSSs, possibly to accommodate
general transcription machinery. Both global and
Figure 1 Summary of AhR enrichment within Cyp1a1 genic region at 2 and 24 hrs. Cyp1a1 is represented by two RefSeq sequences
(NM_009992 and NM_001136059, dark blue tracks) that have different TSSs (dark blue box at far left). The rectangles and lines represent exons
and introns, respectively, and the UTRs are depicted as the thinner rectangles. Arrowhead direction indicates the orientation of the gene. The
grey boxes above represent the Affymetrix 2.0R mouse tiling array probe locations across the Cyp1a1 genic regions. The location and matrix
similarity (MS) scores of the consensus DREs are represented by the purple histogram. The highlighted yellow box identifies bona fide functional
DREs (matrix similarity (MS) score ≥ 0.8473) involved in AhR-mediated Cyp1a1 gene expression. The red boxes identify regions of significant AhR
enrichments (FDR < 0.01) based on the moving average (MA) profile by TileMap. The green histogram plots the log2 fold enrichment values for
each individual probe.
Table 1 Distribution and density analysis of TCDD-induced AhR enriched regions
a in the mouse genome
Genic Region
c
Genome Intergenic DNA
b Intragenic DNA
b 10kb upstream 5’ UTR CDS 3’ UTR
2h r AhR enrichment 14,446 4,163 10,283 4,601 2,569 7,499 225
Enrichment density
d 5.44 2.62 9.64 18.65 17.29 7.21 7.29
24 hr AhR enrichment 974 344 630 306 132 507 9
Enrichment density
d 0.37 0.22 0.59 1.24 0.89 0.49 0.29
a AhR enriched regions with a FDR < 0.01
b intergenic, intragenic and gene regions are defined as previously described in Additional File 1
c regions are defined using the genomic locations in the refGene database from the UCSC Genome Browser
d density calculated per million base pairs
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induced AhR enrichments are more prominent in
regions directly associated with a gene. Nevertheless,
there are a significant number of distally located enrich-
ment sites that may also be functionally relevant.
Confirmation of AhR ChIP-chip Enrichment Analysis
Selected regions of AhR enrichment identified by ChIP-
chip analysis at 2 hrs were confirmed by ChIP-PCR
(Figure 4). Three representative ChIP-chip enrichments
from each genomic region (intergenic, 10 kb upstream of
a TSS, 5’ UTR, CDS and 3’ UTR) were selected to vali-
date AhR enrichments with and without a DRE core at
different positions relative to the TSS. ChIP-PCR and
ChIP-chip analysis of DRE containing regions exhibited
similar levels of AhR enrichment relative to IgGTCDD
controls and were significantly greater than vehicle con-
trols relative to IgGvehicle. AhR enriched regions without
the DRE core were also verified, further demonstrating
that the AhR can interact with DNA independent of a
Figure 2 Characterization of TCDD-induced AhR enriched regions at 2 and 24 hrs (FDR < 0.01). Frequency analysis of enriched regions
relative to log2 fold enrichment at 2 hr (A) and 24 hr (B) illustrating enrichment values in intragenic (light green) and intergenic (dark green)
DNA regions. Distribution of enriched regions relative to region width (C) at 2 hrs (light red) and 24 hrs (dark red) identified 90.5% of enriched
sites were ≤ 1,500 bp. Comparison of AhR enriched regions at 2 and 24 hrs identified 899 overlapping regions (D). Analysis of the fold
enrichment values for the 899 overlapping regions at 2 and 24 hrs identified a positive correlation (two-tailed P-value < 0.0001, Pearson
correlation coefficient = 0.4853; E).
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interaction through DNA looping or protein tethering.
Interestingly, the fold enrichment values for regions with-
out the DRE core were consistently lower than those with
a DRE core, suggesting AhR interactions are stronger in
regions containing a DRE.
DRE Analysis of AhR Enriched Regions
TCDD-elicited changes in gene expression are mediated
through AhR signaling via binding to the substitution
intolerant DRE core sequence (5’-GCGTG-3’). Overlay-
ing TCDD-induced AhR enrichment with DRE core loca-
tions throughout the mouse genome [8] identified 57.8%
and 48.5% of the enriched regions did not contain a DRE
core regions at 2 and 24 hrs, respectively (Table 2 and
Figures 5A-B). Other promoter-specific ChIP-chip stu-
dies have also reported DRE cores in ~50% of the AhR
enriched regions [33,35]. The remaining enriched regions
possessed at least one and as many as 16 DRE cores
(Table 2). AhR enriched regions with or without a DRE
core exhibited similar widths and levels of enrichment.
Matrix similarity (MS) scores have been calculated for
each 19 bp DRE sequence within the mouse genome
using a position weight matrix (PWM) constructed from
bona fide functional DREs [8]. Of the 6,595 significant
AhR enriched regions containing a DRE core (6,093 from
2h ra n d5 0 2f r o m2 4h r ) ,9 0 . 7 %w e r ew i t h i n5 0 0b po fa
DRE core (i.e. distance of maximum enrichment within
the region to an underlying DRE core) with half of these
positions located within 135 bp of a DRE core. However,
only 8.3% and 17.8% of the AhR enriched regions at 2
and 24 hrs, respectively, possessed a putative functional
(high scoring) DRE sequence (MS score ≥ 0.8473) sug-
gesting the AhR may bind other degenerate sequence
elements.
AhR binding to an alternate response element (5’-
CATGN6C[T|A]TG-3’) has also been reported [40,41].
Of the 8,353 and 472 enriched regions at 2 and 24 hrs,
r e s p e c t i v e l y ,t h a td i dn o tc o n t a i naD R Ec o r e ,4 8 2a n d
237, respectively, contained the alternate DRE sequence
(5.8% and 50.2%, respectively). The higher incidence of
AhR enriched regions at 24 hrs containing the alternate
response element may represent tertiary AhR binding
sites resulting from conformational changes and crowd-
ing of the promoter with the general transcription
machinery [42,43].
Transcription Factor Binding Site Over-Representation
Analysis
Significantly AhR enriched regions were computationally
analyzed for over-represented response elements for
known TF binding site (TFBS) families using RegionMiner
(Genomatix). DREs as well other sites for early growth
response (EGR), E2F, nuclear respiratory factor 1 (NRF1),
nuclear receptor subfamily 2 factors (NR2F/COUP-TF)
and peroxisome proliferator-activated receptor (PPAR)
were over-represented within AhR enriched regions
(Table 3; complete list of over-represented TFBS are pro-
vided in Additional Files 6 and 7). Many of these TF sites
were enriched proximally to a DRE core (i.e. within 10-50
bp; Additional File 8) suggesting possible interactions. Stu-
dies have previously reported interactions between AhR
and many of these TFs [34,44,45]. For example, AhR com-
plexes with EGR-1 following treatment of human HUVEC
cells with high glucose concentrations [45]. In addition,
AhR aggregates with E2F1 to inhibit E2F1-induced apop-
tosis [46]. AhR also directly interacts with COUP-TF to
repress ER-mediated gene expression [47].
De Novo Motif Analysis
Approximately 50% of enriched regions lacked the DRE
core sequence (Figures 5A-B) suggesting AhR interacts
with DNA using alternate strategies. De novo motif ana-
lysis of these regions using the Gibbs motif sampler in
CisGenome identified over-representation of comparable
repetitive elements in both the intergenic and intragenic
DNA regions (Additional File 9). Comparison of over-
represented non-repetitive motifs to existing TF binding
motifs in JASPAR and TRANSFAC [48,49] using
STAMP [50] identified similarities to COUP-TF, hepato-
cyte nuclear factor 4 (HNF4), liver receptor homolog 1
(LRH1/NR5A2) and PPAR binding sites (Figure 6).
Interestingly, COUP-TF and HNF4 belong to the NR2F
Figure 3 TCDD-induced AhR enrichment (FDR < 0.01) densities
in the proximal promoter (10 kb upstream and 5 kb
downstream of a TSS) at 2 hrs (A) and 24 hrs (B). The bars
represent the number of enriched regions in each 200 bp window.
The number of DRE cores in 100 bp non-overlapping windows is
superimposed (line) illustrating the overlap between AhR enriched
regions and DRE cores in the proximal promoter region.
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sis of all AhR enriched regions (Table 3). The presence
of these binding motifs in non-DRE containing regions
of AhR enrichment further suggests that AhR-DNA
interactions occur through a tethering mechanism invol-
ving other TFs or by tertiary looping of DNA.
Figure 4 Confirmation of hepatic TCDD-induced AhR enrichment identified by ChIP-chip analysis (FDR < 0.01) at 2 hrs by ChIP-PCR.
Selected regions were chosen for verification based on position relative to a TSS, ChIP-chip fold enrichment and the presence or lack of a DRE
core within the region of enrichment (A). Immunoprecipitated DNA was measured by QRTPCR and AhR enrichment was calculated as fold
induction above IgG controls. The color intensity of each box represents the mean value of three independent replicates. NS = not significant
compared to IgG controls (p < 0.05). 2 hr ChIP-chip enrichment values are provided in Additional File 1.
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Of the 10,369 enrichments identified in the intragenic
DNA regions, 43.8% (4,544/10,369) contained a DRE core
at 2 hrs, and 52.4% (332/634) at 24 hrs (Figure 5, areas
shaded blue). These intragenic AhR enriched regions
mapped to 5,307 and 591 unique genes at 2 and 24 hrs,
respectively (AhR targeted genes are provided as gene
a n n o t a t e de n r i c h e dr e g i o n sin Additional Files 1 and 2).
Molecular and cellular functional analysis using Ingenuity
Pathway Analysis (IPA) found these genes to be associated
with lipid and carbohydrate metabolism, small molecule
biochemistry, cell cycle and gene expression based on a
Fisher’s Exact Test p-value < 0.01 (Figure 7; Additional
Files 10 and 11 list the most significant over represented
biological functions at 2 and 24 hrs). Furthermore, 63.5
and 56.2% of the genes associated with AhR enrichment at
2 and 24 hrs, respectively, contained a DRE core within
the region of enrichment (Figure 8). The higher percen-
tage of genes containing a DRE core compared to enriched
regions with a DRE core is due to multiple regions of AhR
enrichment associated with a single gene (as illustrated for
Cyp1a1 in Figure 1). The remaining genes (36.5% and
54.8% at 2 and 24 hrs, respectively) with significant AhR
enrichment were targeted independently of a DRE core.
At both 2 and 24 hrs, 575 genes had AhR enrichment,
with 513 possessing DRE cores in the AhR enriched
region (Figure 8C). Only 16 genes exhibited AhR enrich-
ment solely at 24 hrs, with three containing a DRE core.
In contrast, 4,732 genes possessed significant AhR
enrichment with 60.4% (2,856) containing a DRE core
within the region of enrichment at 2 hrs. Due to the
large overlap of enriched regions at 2 and 24 hrs, the
remaining analysis focuses predominantly on the AhR
enrichment at 2 hr.
Comparison of Transcriptional Responses with AhR
Enrichment
Gene expression analysis at 2, 4, 8, 12, 18, 24, 72, and
168 hrs identified 1,896 unique differentially expressed
genes (|fold change| ≥ 1.5 and P1(t) > 0.999) at one or
more time points. Of the 1,896 TCDD-responsive
genes, 900 genes (47.5%) possessed significant AhR
enrichment within the intragenic region (10 kb
upstream of the TSS to the end of the transcript).
Moreover, of the 900 genes exhibiting AhR enrichment
at 2 hrs, 625 contained a DRE core sequence, suggest-
ing these responses are AhR-mediated. The remaining
275 differentially expressed genes were not associated
with a AhR enriched region containing a DRE core,
and may be secondary responses. In order to concisely
visualize the integration of the DRE, ChIP-chip and
gene expression analyses, Circos plots were generated
for the genome and individual chromosomes (Figure 9
and Additional File 12). The plots further illustrate the
diversity in AhR enrichment locations in relation to
the genomic position of dysregulated genes. Further
analysis of the responsive genes found that most were
induced by TCDD (Table 4) at all time points. Greater
than 82% of the induced genes at 2 or 4 hrs had signif-
icant AhR enrichment, and more than 62% of them
contained at least one DRE core suggesting that regula-
tion is DRE-dependent fashion. In contrast, only 35%
of the 691 genes induced at 168 hrs, exhibited AhR
enrichment with 26% possessing a DRE core suggesting
that these are secondary gene expression responses.
Interestingly, down-regulated genes associated with
AhR enrichment were relatively consistent across all
time points. Approximately one third of the down-
regulated genes appear to be AhR regulated with DRE
involvement.
Functional analysis of the 900 differentially expressed
genes associated with AhR enrichment was performed
using DAVID [51]. The most over-represented functions
were associated with lipid metabolic processes (enrich-
ment score of 7.34, Table 5), consistent with the induced
fatty liver phenotype [52,53]. IPA analysis of these genes
also identified lipid metabolism as an enriched molecular
and cellular function (Fisher’s Exact Test p-value < 0.01;
Figure 10; Additional File 13 provides a list of the most
significant biological functions). In addition, de novo
motif analysis (Figure 6) identified binding sites for TFs
associated with lipid metabolism and transport. The
Table 2 Distribution of DRE cores in AhR enriched
regions
a
Number of DRE cores
b Number of AhR enriched regions
2h r 2 4h r
0 8,353 472
1 3,705 289
2 1,372 121
3 544 46
4 223 16
5 109 12
66 7 7
72 5 5
81 5 0
91 1 3
10 7 1
11 5 0
12 3 1
13 0 0
14 3 1
15 3 0
16 1 0
Total 14,446 974
a AhR enriched regions with a FDR < 0.01
b 5’-GCGTG-3’ core sequence
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cytochrome P450s, glutathione S-transferases (Gsts) and
UDP-glucuronosyltransferases (Ugts), hallmarks of
TCDD exposure, were also identified as an enriched clus-
ter (enrichment score of 3.54).
Although AhR mediates the expression of enzymes
involved in xenobiotic metabolizing enzymes, including
NADP(H) dehydrogenase, quinone 1 (Nqo1) and UDP-
glucose dehydrogenase (Ugdh) as well as several Ugt
and Gst isoforms, they are also regulated by nuclear fac-
tor, erythroid derived 2, like 2 (Nrf2) via antioxidant
response elements in response to oxidative stress
[54,55]. Recent studies with AhR and Nrf2 null mice
report that TCDD induction of Nqo1 is AhR and Nrf2
dependent [56]. Furthermore, specific Ugt and Gst iso-
forms induced by TCDD require Nrf2. Collectively,
these responses are referred to as the “TCDD-inducible
AhR-Nrf2 gene battery.” ChIP-chip and gene expression
Figure 5 Mapping TCDD-induced AhR enriched regions (FDR < 0.01) with DRE locations. Regions of enrichment identified in the
intergenic (purple) and intragenic (blue) DNA regions of the genome at 2 hrs (A) and 24 hrs (B) were searched for high scoring (putative
functional) DRE sequences (matrix similarity score ≥ 0.8473; dark blue and dark purple segments) and low scoring DRE sequences (matrix
similarity score < 0.8473; mid blue and mid purple segments) using a position weight matrix developed from bona fide functional DREs [8]. Light
blue and light purple segments represent regions with no DRE core sequence. A total of 6,595 enriched regions (6,093 at 2 hrs and 502 at 24
hrs) contained at least one DRE core (5’-GCGTG-3’). 50% of these regions were within 135 bp of a DRE core (based on the location of maximum
enrichment within the enriched region; C).
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Nrf2 induction is associated with AhR enrichment.
Although supportive of the Nrf2-dependency model,
these data do not distinguish if these are secondary
responses mediated by Nrf2 alone, or involve an AhR-
Nrf2 interaction. In contrast, Gsta1 and Ugt2b35 induc-
tion occurred independently of AhR enrichment, sug-
gesting they may only be dependent on Nrf2 [56].
Immune cell accumulation following a single acute dose
of TCDD at 168 hrs is presumed to be a secondary
Table 3 Significantly over-represent transcription factor module families in TCDD-induced AhR enriched regions
a
TF Module
Family
Module Description 2 hr AhR enriched regions 24 hr AhR enriched regions
#o f
matches
Expected #
of matches
Over-
representaion
b
Z-
Score
#o f
matches
Expected #
of matches
Over-
representaion
b
Z-
Score
AHR AhR-ARNT heterodimer 9,447 4,278.30 2.21 79.03 851 297.44 2.86 32.07
SP1 GC-Box factors SP1/GC 19,356 12,839.04 1.51 57.54 1,346 892.61 1.51 15.17
HIF Hypoxia inducible factor,
bHLH/PAS protein family
8,763 4,841.13 1.81 56.37 569 336.57 1.69 12.64
E2F E2F-Myc activator/cell cycle
regulator
18,247 12,444.88 1.47 52.04 1,266 865.21 1.46 13.62
ZBP Zinc binding protein factors 25,542 18,518.20 1.38 51.65 1,739 1,287.45 1.35 12.58
NRF1 Nuclear respiratory factor 1 3.475 1,494.81 2.32 51.21 252 103.92 2.42 14.48
ZF5 ZF5 POZ domain zinc finger 3,156 1,442.92 2.19 45.09 205 100.32 2.04 10.40
NF1 Nuclear factor 1 13,047 8,876.90 1.47 44.27 886 617.15 1.44 10.81
NR2F Nuclear receptor subfamily 2
factors
44,774 36,390.64 1.23 44.02 3,180 2,530.00 1.26 12.93
EGR EGR/nerve growth factor
included protein c
22,224 16,794.62 1.32 41.92 1,541 1,167.62 1.32 11.
PPAR Peroxisome proliferator-
activated receptor
24,808 19,035.70 1.30 41.87 1,752 1,323.43 1.32 11.78
RXR RXR heterodimer binding
sites
41,027 33,441.00 1.23 41.54 2,932 2,324.93 1.26 12.60
WHN Winged helix binding sites 3,030 1,477.23 2.05 40.39 206 102.70 2.01 10.14
a AhR enriched regions with a FDR < 0.01
b total number of matches in enriched regions/expected number of matches in genome
Complete list of over-represented TF module families are provided in Additional Files 6 and 7
Figure 6 De novo motif analysis of intragenic (A) and intergenic (B) AhR enriched regions lacking a DRE core. The non-repetitive over-
represented motifs from each region are shown with their consensus and reverse complement sequence, and the Gibbs motif sampler score.
Over-represented motifs were associated with specific TFBSs in JASPAR and TRANSFAC based on the consensus sequence alignments and E-
value scores.
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Page 9 of 19Figure 7 Molecular and cellar functions over-represented by genes associated with significant AhR enrichment (FDR < 0.01)
containing a DRE core. The 4,544 and 332 unique genes with AhR enrichment with a DRE core at 2 hrs (A) and 24 hrs (B), respectively, were
analyzed using Ingenuity Pathway Analysis for enriched biological functions using Fisher’s Exact Test (p < 0.01; orange line). The blue bars
represent the log Odds value calculated from the p-value of each functional group.
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Page 10 of 19response to hepatic injury or fatty acid accumulation
[52,53]. DAVID analysis of genes induced at 168 hrs iden-
tified multiple over-represented immune-related clusters
(enrichment scores > 2). However, several of the genes
including complement component 1, q subcomponent,
beta polypeptide (C1qb), CD36 antigen (Cd36), comple-
ment component 4A (C4a) and interferon regulatory
factor 8 (Irf8), did not exhibit accompanying AhR enrich-
ment within their intragenic region (10 kb upstream of the
TSS to the end of the 3’ UTR). Only 26 out of 105 differ-
entially regulated genes in the enriched immune clusters
exhibited AhR enrichment. Collectively, these data suggest
that gene expression associated with immune function is a
consequence of immune cell infiltration into the liver.
Figure 8 Mapping TCDD-induced AhR enriched regions (FDR < 0.01) and DRE analysis to genes. The 10,283 and 660 AhR enrichments
within the intragenic DNA regions at 2 and 24 hrs (blue shaded areas in Figures 5A-B) mapped to 5,307 (A) and 591 (B) distinct genes based
on the refGene data from the UCSC Genome Browser. These genes were searched for the presence of high (matrix similarity score (MS) ≥
0.8473; dark grey areas) and low (MS score < 0.84731; light grey areas) scoring DRE sequences, and the absence of a DRE core (white areas)
within the region of AhR enrichment. Comparing 2 and 24 hrs data identified 575 overlapping genes with AhR enrichment and 513 of these
genes contained a DRE core within the region of enrichment (C).
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This study further elucidates the role of the AhR in
mediating the hepatic effects of TCDD in C57BL6
mice. Recent studies have mapped AhR binding using
promoter-focused ChIP-chip arrays and found that
~50% of the AhR enriched regions were devoid of the
D R Ec o r e[ 3 2 - 3 4 ] .T h el a c ko faD R Ec o r ei nr e g i o n s
of AhR enrichment was also reported in a AhR
Figure 9 Circos plots integrating DRE analysis, AhR enrichment (2 hrs; FDR < 0.01) and heatmaps for hepatic differential gene
expression responses (|fold change| ≥ 1.5 and P1(t) > 0.999) induced by TCDD across the genome (A) and chromosome 9 (B). The
inset legend image provides information represented by each data ring. DRE matrix similarity (MS) scores and AhR enrichment values increase
radially outward. The time points for the gene expression heatmaps also increase radial outward. The arc of each heatmap wedge maps directly
to the location of the gene in the genome. The arc length is proportional to the length of the transcribed region. Circos plots for the other
chromosomes are provided in Additional File 12.
Table 4 Distribution and AhR enrichment and DRE analysis of differentially expressed genes elicited by TCDD
2
hr
4
hr
8
hr
12
hr
18
hr
24
hr
72
hr
168
hr
Number of differentially expressed
genes
a
Up-regulated Total 68 255 341 218 236 287 267 719
With AhR enrichment
b 55 200 202 148 172 186 164 243
With AhR enrichment
b + DRE
core
c
47 168 171 126 146 156 135 181
Down-
regulated
Total 18 233 116 168 105 237 261 218
With AhR enrichment
b 10 123 76 102 59 131 137 123
With AhR enrichment
b + DRE
core
c
6 7 9 4 9 6 33 07 27 9 7 0
a |fold-change| ≥ 1.5 and P1(t) > 0.999
b AhR enriched regions at 2 hrs with FDR < 0.01
c 5’-GCGTG-3’ core sequence within AhR enriched region
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Page 12 of 19genome-wide ChIP-chip study performed in mouse
CH12.LX cells [57]. ChIP-seq experiments for other
TFs have also demonstrated enrichment in remote
genome regions, which may serve important regulatory
roles [10,11,14,17]. Collectively these data suggest the
AhR uses different mechanisms to regulate gene
expression. Moreover, the integration of genome-wide
in silico DRE search, with de novo motif analysis and
TCDD-elicited hepatic temporal gene expression data
has further elucidated the hepatic AhR gene regulatory
network.
ChIP-chip analysis identified 14,446 TCDD-induced
AhR regions at 2 hrs and 974 regions at 24 hrs, consis-
tent with the rapid nuclear export and subsequent
degradation of the AhR following TCDD activation [37].
Approximately half of these regions were within intra-
genic regions (10 kb upstream of a TSS to the end of
the 3’ UTR). Furthermore, 25% of these enriched regions
at 2 hrs and 19% at 24 hrs were within 2 kb of a TSS,
indicating that a large subset of AhR enrichment occurs
adjacent to a TSS. Unlike other studies that report a
normal distribution of TF binding centered around the
Table 5 Functional enrichment analysis of differently regulated
a genes with AhR enrichment
b using DAVID
Category Team Gene Count Fold enrichment P-value
Enrichment Score: 7.34
GOTERM_BP_3 GO:0006629 ~ lipid metabolic process 76 2.23 5.53E-11
GOTERM_BP_3 GO:0044255 ~ cellular lipid metabolic process 53 2.23 7.80E-08
GOTERM_BP_3 GO:0008610 ~ lipid biosynthetic process 32 2.30 2.28E-05
Enrichment Score:4.12
GOTERM_BP_3 GO:0048523 ~ negative regulation of cellular process 94 1.60 4.46E-06
GOTERM_BP_3 GO:0048519 ~ negative regulation of biological process 101 1.54 7.83E-06
GOTERM_BP_3 GO:0031324 ~ negative regulation of cellular metabolic process 45 1.85 8.99E-05
GOTERM_BP_3 GO:0051172 ~ negative regulation of nitrogen compound metabolic process 39 1.96 9.68E-05
GOTERM_BP_3 GO:0009890 ~ negative regulation of biosynthetic process 40 1.86 2.33E-04
GOTERM_BP_3 GO:0009892 ~ negative regulation of metabolic process 46 1.74 3.20E-04
GOTERM_BP_3 GO:0010605 ~ negative regulation of macromolecule metabolic process 43 1.72 6.88E-04
Enrichment Score: 3.54
GOTERM_BP_3 GO:0009410 ~ response to xenobiotic stimulus 8 10.59 3.54E-06
GOTERM_BP_3 GO:0006805 ~ xenobiotic metabolic process 7 11.59 1.12E-05
GOTERM_BP_3 GO:0018894 ~ dibenzo-p-dioxin metabolic process 3 19.86 7.31E-03
GOTERM_BP_3 GO:0009404 ~ toxin metabolic process 3 11.92 2.28E-02
Enrichment Score: 2.70
GOTERM_BP_3 GO:0051272 ~ positive regulation of call motion 9 4.58 6.00E-04
GOTERM_BP_3 GO:0051270 ~ regulation of cell motion 15 2.84 7.55E-04
GOTERM_BP_3 GO:0040017 ~ Positive regulation of locomotion 9 4.26 1.01E-03
GOTERM_BP_3 GO:0030334 ~ regulation of cell migration 13 2.87 1.76E-03
GOTERM_BP_3 GO:0040012 ~ regulation of locomotion 13 2.39 7.93E-03
GOTERM_BP_3 GO:0040012 ~ regulation of localization 32 1.61 9.36E-03
Enrichment Score: 2.55
GOTERM_BP_3 GO:0048518 ~ positive regulation of biological process 106 1.44 7.45E-05
GOTERM_BP_3 GO:0048522 ~ positive regulation of cellular process 94 1.45 2.03E-04
GOTERM_BP_3 GO:0009893 ~ positive regulation of metabolic process 51 1.53 2.64E-03
GOTERM_BP_3 GO:0010604 ~ positive regulation of macromolecule metabolic process 48 1.54 3.02E-03
GOTERM_BP_3 GO:0031325 ~ positive regulation of cellular 47 1.48 6.67E-03
GOTERM_BP_3 GO:0009891 ~ positive regulation of biosynthetic 38 1.38 3.96E-02
GOTERM_BP_3 GO:0031325 ~ positive regulation of nitrogen compound metabolic process 36 1.39 4.40E-02
Enrichment Score: 2.44
GOTERM_BP_3 GO:0005996 ~ monosaccharide metabolic process 21 2.27 9.50E-04
GOTERM_BP_3 GO:0005975 ~ carbohydrate metabolic process 37 1.67 2.63E-03
GOTERM_BP_3 GO:0016051 ~ carbohydrate biosynthetic process 11 2.70 7.19E-03
GOTERM_BP_3 GO:0044262 ~ cellular carbohydrate metabolic process 27 1.70 9.34E-03
a |fold-change| ≥ 1.5 and P1(t) >0.999 at one or more time points
b AhR enriched regions at 2 hrs with FDR < 0.01
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Page 13 of 19TSS [15,58-60], the AhR density profile exhibited a cleft
immediately adjacent to the TSS, possibly to accommo-
date recruited transcriptional machinery.
Although most AhR enrichment regions are intragenic,
a significant number are located in distal intergenic
regions (i.e. 4,163 of 14,446 at 2 hrs and 344 of 974 at 24
hrs). Studies with the ER, p53 and forkhead box protein
A1 [10,11,14,17] suggest distal TF binding may have dis-
tinct regulatory roles. Binding proximal to the TSS is pre-
sumed to stabilize the general transcriptional machinery,
while distal binding regulates transcription by a looping
mechanism or by altering chromatin structure [9,61,62].
Consequently, AhR binding outside of the proximal pro-
moter region may have important regulatory roles that
remain largely uninvestigated.
Comparing AhR enriched regions with DRE cores
revealed that their intergenic, intragenic and genic (10 kb
upstream, UTRs, and CDS) density distributions were
similar. The greatest density of AhR enrichment asso-
ciated with a DRE core occurred within the proximal
promoter. Both exhibited comparable distribution pro-
files except for the cleft in enrichment at the TSS. The
decrease in AhR enrichment at the TSS coincides with
RNA polymerase II binding at the TSSs [10] of transcrip-
tionally responsive genes. Although TCDD-elicited differ-
ential gene expression is thought to be mediated by the
substitution intolerant DRE core sequence (5’-GCGTG-
3’), only ~50% of the AhR enriched regions contained a
DRE core, consistent with findings in other promoter tar-
geted AhR ChIP-chip studies [33,35] (Lo et al., in sub-
mission). Moreover, relatively few alternative AhR
response elements (5’-CATGN6C[T|A]TG-3’)[ 4 0 , 4 1 ]
were identified in AhR enriched regions lacking a DRE
core sequence. Enrichment in regions lacking DRE cores
provides additional evidence of AhR-DNA interactions
that don not involve the basic bHLH domain [63], such
as tethering to other DNA interacting TFs and/or tertiary
interactions with looping DNA.
Integration of gene expression, ChIP-chip, and DRE
distribution data suggests that ~35% of all differentially
expressed hepatic genes are mediated by direct AhR
binding to a DRE. Consequently, 65% of the gene expres-
sion responses elicited by TCDD do not involve direct
AhR binding to a DRE. However, TF binding analyses
based on tiling arrays is limited by the extent of probe
coverage (Figure 1). Genomic regions lacking probe cov-
erage may falsely inflate the number of DRE-absent AhR
enriched regions, thus underestimating the number of
AhR regulated genes involving a DRE. Furthermore, the
analyses may not be exhaustive due to the technical lim-
itations of ChIP-chip assay coupled with the conservative
FDR threshold used to identify statistically significant sig-
n a l s ,w h i c hm a yh a v ee x c l u d e ds o m ep o s i t i v es i g n a l s .
These limitations of the technology could be addressed
in ChIP-seq experiments, which have greater resolution
and sensitivity [64,65]. The shorter sequence reads would
improve resolution, but may also identify fewer regions
containing a DRE. The higher sensitivity of ChIP-seq
could also identify additional regions of AhR enrichment.
ChIP-seq studies could also confirm AhR binding in
these genomic regions in either a DRE-dependent or -
independent manner.
TCDD induces hepatic vacuolization and lipid accumu-
lation with differential gene expression associated with
fatty acid metabolism and transport [25,53]. Independent
functional annotation analysis of differentially expressed
genes with significant AhR enrichment using DAVID and
IPA identified over-represented processes related to fatty
acid and lipid metabolism. Computational analysis
also identified over-represented binding motifs for TFs
involved in the regulation of lipid and cholesterol metabo-
lism, including sites for HNF4, LXR, PXR, PPAR and
COUP-TF. COUP-TF is a potent repressor that antago-
nizes transcriptional responses mediated by other nuclear
receptors including HNF4, PPAR, ER, RAR and VDR [66].
For example, COUP-TF antagonizes HNF4a-mediated
responses by binding HNF4a response elements [67-71].
Furthermore, AhR interactions with COUP-TF repress
ER-mediated gene expression responses [47]. Therefore,
AhR interactions with COUP-TF may regulate lipid and
fatty acid metabolism by blocking HNF4a target gene
expression (Figure 10A). Coincidentally, the HNF4 binding
motif is over represented within AhR enriched regions
lacking a DRE core.
Consistent with this proposed mechanism, several
HNF4a regulated genes, including Cyp7a1 and Gck,
exhibited AhR enrichment and were repressed by
Figure 10 Molecular and cellar functions over-represented by
differentially regulated genes (|fold change| ≥ 1.5, P1(t) >
0.999) associated with significant AhR enrichment (FDR < 0.01)
at 2 hrs. The 900 differentially regulated genes with AhR
enrichment were analyzed using Ingenuity Pathway Analysis for
enriched biological functions using Fisher’s Exact Test (p < 0.01;
orange line). The blue bars represent the log Odds value calculated
from the p-value of each functional group.
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Page 14 of 19TCDD. Cyp7a1 is the rate-limiting enzyme in the bile
acid biosynthetic pathway that converts cholesterol into
bile acids. Transgenic mice over-expressing Cyp7a1 are
protected from high-fat diet induced obesity, fatty liver
and insulin resistance [72]. Moreover, a genetic defi-
ciency of Cyp7a1 in humans results in hyperlipidemia
[73]. Gck phosphorylates glucose in the initial step of
glycolysis. Mutations in Gck that reduce kinase activity
are associated with insulin resistance and maturity onset
diabetes of young 2 (MODY2) in humans [74-76].
Furthermore, mice over-expressing Gck are resistant to
MODY2 [77]. The down-regulation of Cyp7a1 and Gck,
possibly due to AhR - COUP-TF interactions at HNF4a
response elements, is consistent TCDD-induced hepatic
lipid accumulation in mice. Interestingly, TCDD expo-
sure has been linked to diabetes and metabolic syn-
drome in humans [78-84]. Studies examining AhR-
COUP-TF interactions and their effects on HNF4 target
gene expression are being investigated further.
Conclusion
This study identified the genome-wide locations of
TCDD-induced hepatic AhR enrichment in vivo and
incorporates DRE distribution and differential gene
expression data to further elucidate the hepatic AhR regu-
latory network. In addition to identifying interactions in
regions associated with genes, AhR enrichment in distal
non-coding intergenic regions was characterized. The
functional significance of these distal interactions is
unknown but intergenic binding has been reported for
other TFs, and warrants further investigation. Moreover,
only ~50% of all AhR enriched regions involved a DRE,
suggesting that indirect AhR binding to DNA plays a sig-
nificant role in the AhR regulatory network.
Methods
Animal Handling and Treatment
Hepatic tissue samples from immature female ovariecto-
mized C57BL/6 mice obtained from a previous study [53]
were used for both ChIP assays at 2 and 24 hrs, and gene
expression analyses across all time points. Briefly, mice
were orally gavaged with 30 μg/kg TCDD and sacrificed
by cervical dislocation at 2, 4, 8, 12, 18, 24, 72 or 168 hrs
postdose. Tissues were removed, weighed, and multiple
samples (~100 mg each) were flash frozen in liquid nitro-
gen and stored at -80°C until further use.
Chromatin Immunoprecipitation (ChIP) and ChIP-chip
Experiments
ChIP assays were performed as previously described [33]
with the following changes. Approximately 100 mg of
mouse liver was homogenized in 1% formaldehyde and
incubated for 10 min at room temperature. Tissue
homogenate was centrifuged at 10,000 RPM for 3 min
at 4°C. Pellet was washed in ice-cold PBS, centrifuged,
and resuspended in 900 μLo fT S E I( 2 0m MT r i s - H C l
[pH 8.0], 150 mM NaCl, 2 mM EDTA, 1% Triton
X-100, 0.1% sodium dodecyl sulfate) + 1× Protease Inhi-
bitor Cocktail (Sigma, St. Louis, MO). Samples were
sonicated 12 times for 10 s each time at 25% amplitude
using a Branson 450 sonifier. Supernatant was trans-
ferred to fresh microcentrifuge tubes and incubated with
rabbit IgG (5 μg; Sigma) and anti-AhR (5 μg; SA-210,
Biomol) overnight at 4°C under gentle agitation. ChIP
samples were washed and the DNA was isolated as pre-
viously described [33]. For ChIP-chip experiments,
immunoprecipitated DNA isolated following immuno-
precipitation with anti-AhR of liver extracts from
TCDD-treated mice was linearly amplified using a
whole genome amplification kit according to the manu-
facturer’s instructions (Sigma). Linearly amplified DNA
(7.5 μg) was fragmented by limited DNAseI digestion
and hybridized to Affymetrix GeneChip
® mouse 2.0R
tiling arrays (Affymetrix, Santa Clara, CA) as previously
described [33]. The hybridization and washing steps
were performed according to the manufacturer’sp r o t o -
col at the Centre for Applied Genomics (Toronto,
Canada). Data were normalized and analyzed using Cis-
Genome and mapped against mouse genome version
mm9 [36]. Enriched regions with a false discovery rate
(FDR) of 1.0% (0.01) were determined by comparing tri-
plicate samples of AhRTCDD to triplicate IgGTCDD using
a moving average (MA) approach with default settings
in TileMap v2 [85]. Regions were merged if the gap
between them was < 300 bp and the number of probes
failing to reach the cut-off was < 5. Regions were dis-
carded if they were < 120 bp or did not contain at least
5 continuous probes above the cut-off. ChIPed DNA
was purified using the PCR purification kit from BioBa-
sic Inc. (Markham, ON) and quantified using quantita-
tive real-time PCR (QRTPCR) (KAPA SYBR Fast qPCR
Master Mix; KAPA Biosystems, Toronto, ON) (ChIP-
PCR). Fold enrichment values were calculated relative to
IgG controls. ChIP-PCR primer sequences are provided
in Additional File 14.
ChIP-chip Location Analysis
The mouse genomic assembly (mm9) and associated
annotation within the refGene and refLink databases
were downloaded from the UCSC Genome Browser [86].
Individual segments of a gene region (i.e. the 10 kb
sequence upstream of a TSS, the 5’ and 3’ UTRs and the
CDS) for each mature gene encoding reference sequence
(RefSeqs with NM prefixed identifiers) were determined
using the genomic coordinates within the refGene data-
bases (Additional File 3). Intragenic DNA regions within
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overlapping gene regions (Additional File 3) from both
strands of the genome, and the DNA between adjacent
intragenic regions are defined as the non-transcribed
intergenic DNA regions (Additional File 3). AhR enrich-
ment densities were calculated based on the number of
significant enriched regions occurring in an interrogated
region (e.g. intergenic DNA region or 5’ UTR) divided by
the total sum of the region length. Gene annotation asso-
ciated with each RefSeq sequence was derived from the
refLink database in the UCSC Genome Browser.
Transcription Factor Motif Analysis
The locations of AhR enrichment were compared
against 5’-GCGTG-3’ DRE core sequence locations in
the mouse genome [8]. Identification of TF motifs
over-represented in regions containing a DRE core
were performed using the default parameter settings in
RegionMiner, a program within the Genomatix suite of
applications http://www.genomatix.de that contains an
extensive database of TF binding motifs. Identified
module families and individual matrices with z-scores
> 3 were considered significant [87]. De novo motif
discovery was performed using the Gibbs motif sam-
pler in CisGenome on AhR regions of enrichment
sequences not containing a DRE. Matrices for over-
represented motifs were compared to existing TF bind-
ing motifs in JASPAR and TRANSFAC [48,49] using
STAMP [50].
Comparison with Microarray Gene Expression
Results from the ChIP-chip and DRE analysis were inte-
grated with whole-genome gene expression profiling data
from mice orally gavaged with 30 μg/kg TCDD using 4 ×
44 k whole-genome oligonucleotide arrays from Agilent
Technologies (Santa Clara, CA) [8]. The genomic loca-
tions of the differentially responsive genes (|fold change|
≥ 1.5 and P1(t) > 0.999) were obtained for each RefSeq
sequence associated with the gene from the refGene
database in the UCSC Genome Browser. Circos plots
[88] were generated to visualize the locations of DRE
cores, regions of AhR enrichment and temporal heat-
maps of temporal gene expression responses.
Functional Annotation and Pathway Analysis
Functional annotation clustering of Gene Ontology
(GO) terms for genes associated with significant AhR
enrichment was performed using DAVID (Database for
Annotation, Visualization, a n dI n t e g r a t e dD i s c o v e r y )
[51]. In addition, the regions were analyzed using Inge-
nuity Pathway Analysis (IPA; http://www.ingenuity.
com/) to identify over-represented molecular and cel-
lular functions based on the Fisher’sE x a c tT e s t
p-value < 0.01.
Additional material
Additional file 1: Genomic location, gene annotation and
enrichment values of significant (FDR < 0.01) TCDD-induced AhR
enrichment at 2 hrs. Detailed results of the AhR ChIP-chip analysis that
include the genomic location and TCDD-induced enrichment values, and
the gene annotation of enrichment peaks located within the 10 kb
upstream and transcribed region of a gene.
Additional file 2: Genomic location, gene annotation and
enrichment values of significant (FDR < 0.01) TCDD-induced AhR
enrichment at 24 hrs. Detailed results of the AhR ChIP-chip analysis
that include the genomic location and TCDD-induced enrichment values,
and the gene annotation of enrichment peaks located within the 10 kb
upstream and transcribed region of a gene.
Additional file 3: Definitions of various genomic regions used to
map regions of AhR enrichment. A) Genomic locations from the UCSC
Genome Browser refGene database were used to obtain sequences for
10 kb region upstream of the TSS, the 5’ and 3’ UTRs, and the CDS of
every known human, mouse and rat RefSeq sequence. A gene region is
defined as the sequence spanning the region 10 kb upstream of a TSS
through to the end of the 3’ UTR. B) Intragenic DNA regions in a
genome were determined by combining the non-overlapping gene
regions. For example, gene regions of tissue specific isoforms of a gene
that have different TSS positions were merged to determine the longest
spanning range (genes C & C’ and genes E & E’). Additionally,
overlapping genes on both strands of the genome were also merged
(genes B + E + E’). Non-transcribed DNA segments that span the regions
between adjacent intragenic regions are defined as the intergenic DNA
regions.
Additional file 4: TCDD-induced AhR enrichment (FDR < 0.01)
density across the mouse genome at 2 hrs. The density of significant
AhR enrichment (per Mbp) at 2 hrs were calculated for each of the
defined genomic regions across the individual chromosomes.
Additional file 5: TCDD-induced AhR enrichment (FDR < 0.01)
density across the mouse genome at 24 hrs. The density of significant
AhR enrichment (per Mbp) at 24 hrs were calculated for each of the
defined genomic regions across the individual chromosomes.
Additional file 6: Transcription factor binding site analysis of
significant TCDD-induced AhR enrichment (FDR < 0.01) at 2 hrs.
DNA sequences for the regions of significant AhR enrichment at 2 hrs
were analyzed for transcription factor (TF) binding site motif over-
representation using RegionMiner. The results list the TF matrices and
their corresponding over-representation and z-score value.
Additional file 7: Transcription factor binding site analysis of
significant TCDD-induced AhR enrichment (FDR < 0.01) at 24 hrs.
DNA sequences for the regions of significant AhR enrichment at 24 hrs
were analyzed for transcription factor (TF) binding site motif over-
representation using RegionMiner. The results list the TF matrices and
their corresponding over-representation and z-score value.
Additional file 8: Over-representation of transcription factor
binding motifs located proximally (10-50 bp) of a DRE in a
significantly AhR enriched region (FDR < 0.01). DNA sequences for
the regions of significant AhR enrichment at 2 and 24 hrs possessing a
DRE core sequence (5’-GCGTG-3’) were analyzed for transcription factor
(TF) binding site motif over-representation using RegionMiner. The results
list the TF matrices and their corresponding over-representation and
z-score value.
Additional file 9: Repetitive sequence elements identified in the de
novo motif analysis of significant intragenic and intergenic AhR
enriched regions (FDR < 0.01) lacking a DRE core. The repetitive
over-represented motifs from each region are shown with their
consensus and reverse complement sequence, and the Gibbs motif
sampler score.
Additional file 10: Pathway analysis of genes associated with DRE-
containing regions of AhR enrichment (FDR < 0.01) at 2 hrs. List of
the most significant Bio-Functions (p < 0.01) identified using Ingenuity
Pathway Analysis for the genes associated with a significant AhR
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Page 16 of 19enriched region (FDR < 0.01) containing a DRE core (5’-GCGTG-3’)a t
2 hrs.
Additional file 11: Pathway analysis of genes associated with DRE-
containing regions of AhR enrichment (FDR < 0.01) at 24 hrs. List of
the most significant Bio-Functions (p < 0.01) identified using Ingenuity
Pathway Analysis for the genes associated with a significant AhR
enriched region (FDR < 0.01) containing a DRE core (5’-GCGTG-3’)a t
24 hrs.
Additional file 12: Circos plots integrating DRE analysis, AhR
enrichment (2 hrs; FDR < 0.01) and heatmaps for hepatic
differential gene expression responses (|fold change| ≥ 1.5 and P1
(t) > 0.999) induced by TCDD across the genome. Circos plots
illustrate the ideograms for each individual chromosome and the entire
genome and integrate the results of the DRE, ChIP-chip and gene
expression analyses.
Additional file 13: Pathway analysis of differentially regulated
genes (|fold change| ≥ 1.5 and P1(t) > 0.999) associated with
regions of AhR enrichment (FDR < 0.01) at 2 hrs. List of the most
significant Bio-Functions (p < 0.01) identified using Ingenuity Pathway
Analysis for TCDD-elicited gene expression responses (|fold change| ≥ 1.5
and P1(t) > 0.999) associated with a significant AhR enriched region (FDR
< 0.01) containing a DRE core (5’-GCGTG-3’) at 24 hrs.
Additional file 14: Primer sequences used to verify 2 hr ChIP-chip
responses. QRTPCR primers used to verify AhR enriched regions isolated
from the 2 hr ChIP-chip.
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